Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3772271
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants […]
MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics
Manuscript describes preclinical development of MGC018Phase 1 dose expansion trial evaluating MGC018 in patients with mCRPC, TNBC and NSCLC is […]
36Kr Holdings Inc. Announces Strategic Collaboration with Youku to Enhance Content Commercialization
BEIJING, Sept. 23, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and […]
Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
CAMBRIDGE, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed […]
Freeline announces supply agreement for haemophilia B program
LONDON, Sept. 23, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical stage, […]
Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy
BUFFALO, N.Y., Sept. 23, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, […]
Lantronix Announces Ultra-Compact Open-Q 865XR System on Module (SOM) to Power Internet of Things Solutions
IRVINE, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX) a global provider of Software as a Service […]
AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s Disease
Genentech disclosed that the anti-Tau antibody did not meet the co-primary efficacy endpoint or two secondary endpoints in the TAURIEL […]
Akoustis Receives XBAW RF Filter Design Win and Order from New 5G Small Cell Infrastructure Customer
– Band n79 Filter for New Small Cell Product Aimed at 5G Network Operators –– Akoustis Expects Production Ramp in […]
Hamilton Lane Names Paul Yett as Director of ESG & Sustainability
BALA CYNWYD, Pa., Sept. 23, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane (NASDAQ: HLNE) today […]
